Bob Saget was best known for being an actor and a comedian. But he was also very active in a nonprofit here in the Bay Area – the Scleroderma Research Foundation.
Bob Saget was best known for being an actor and a comedian. But he was also very active in a nonprofit here in the Bay Area – the Scleroderma Research Foundation.
Bob Saget was best known for being an actor and a comedian. But he was also very active in a nonprofit here in the Bay Area – the Scleroderma Research Foundation.
April 29 Alliance for Cancer Gene Therapy Summit 2021 Features World Renowned Cancer Researchers Advancing Solid Tumor Breakthroughs
Share Article
James P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote the Summit
Nobel Laureate James P. Allison, PhD, Carl H. June, MD and Pulitzer-prize winning author Siddhartha Mukherjee, MD will be the keynote speakers at the virtual Alliance for Cancer Gene Therapy Summit 20
It’s so rare to have the opportunity to hear from the world’s top cancer researchers, biotechs, investors and patients all in the same room. We’re excited to have Alliance for Cancer Gene Therapy be a catalyst for these important conversations that could potentially saving lives.
Alliance for Cancer Gene Therapy Summit 2021 Features World Renowned Cancer Researchers Advancing Solid Tumor Breakthroughs
Share Article
James P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote April 29 Summit
Nobel Laureate James P. Allison, PhD, Carl H. June, MD and Pulitzer-prize winning author Siddhartha Mukherjee, MD will be the keynote speakers at the virtual Alliance for Cancer Gene Therapy Summit
It’s so rare to have the opportunity to hear from the world’s top cancer researchers, biotechs, investors and patients all in the same room STAMFORD, Conn. (PRWEB) April 16, 2021 April 29 marks a pivotal moment in cancer research when the world’s brightest minds come together to discuss how to translate the success of CAR T-cell therapies for blood cancers into successful cell and gene therapies for the most complex and deadly solid tumor cancers. The scientists and companies driving